Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...

Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...

1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.

Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...

Cancer Res (2022) 82 (22_Supplement): PR006.

1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, ...

1Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2Center for Human Immunobiology, Department of Medicine, Feinberg ...

Abstract. TNG462 is a clinical-stage, MTA-cooperative PRMT5 inhibitor currently being evaluated in an ongoing phase I/II clinical trial for solid tumors with MTAP loss. Approximately 10-15% of all ...

1Yonsei University, College of Medicine, Seoul, Republic of Korea.

1Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York.